GrantExec, a Euna Solutions® company

Grants for Public housing authorities - Health

Explore 2,127 grant opportunities

BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Contact for amount
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 9, 2024

Date Added

Mar 31, 2023

The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Education
State governments
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 15, 2024

Date Added

Jul 19, 2023

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research for developing and testing new care models that effectively combine HIV, addiction, and primary care services to improve health outcomes for individuals at high risk for or living with HIV, Hepatitis, and substance use disorders in the US.

Education
State governments
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
$499,999
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 5, 2024

Date Added

Jan 12, 2023

This funding opportunity supports researchers in studying and characterizing genetically modified mice that exhibit early life lethality or reduced viability, contributing to our understanding of gene function and its implications for human health.

Health
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for Strategies for Preventing Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes (Collaborative UG3/UH3 Clinical Trial Required)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 14, 2024

Date Added

Feb 25, 2024

The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Request for Applications (RFA) seeking applications for a multisite clinical trial that will test a screening approach to identify coronary atherosclerosis and test interventions to reduce the progression of coronary atherosclerosis. There will be only one award for this RFA. The planned RFA will utilize the UG3/UH3 activity code with details provided below. The planned RFA will support a Clinical Coordinating Center (CCC) and will run in parallel with a companion RFA for a collaborating Data Coordinating Center (DCC) application.This RFA will accept only an application that is part of a collaborative pair of applications. The pair must include one application to the CCC UG3/UH3 Notice of Funding Opportunity (NOFO) plus one application to the companion DCC U24 NOFO.Both a CCC application and a collaborating DCC application must be submitted on the same due date for consideration by NHLBI. CCC (UG3/UH3) applications submitted without a collaborative DCC (U24) application will be deemed incomplete and will not proceed to review. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The planned RFAs are expected to be published in Summer 2024 with an expected application due date in Fall 2024.

Health
State governments
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
$450,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 5, 2024

Date Added

Jan 13, 2023

Reissue of RFA-MH-20-401.This Funding Opportunity Announcement (FOA) supports pilot work for subsequent studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resource mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders, etc.) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations.

Health
State governments
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 25, 2025

Date Added

Jul 7, 2022

This grant provides funding for large-scale, collaborative research projects that explore complex questions related to aging, requiring a multidisciplinary team and integration of various components across institutions.

Health
State governments
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 7, 2024

Date Added

Nov 21, 2022

This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R61/R33) mechanism to provide up to 2 years of R61 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

Health
State governments
Single Family 2024
Contact for amount
Minnesota Housing
State

Application Deadline

Jul 11, 2024

Date Added

Jun 7, 2024

The Minnesota Housing, in collaboration with Greater Minnesota Housing Fund (GMHF), is launching the Single Family RFP through its Community Homeownership Impact Fund. This initiative is designed to expand and preserve affordable homeownership opportunities across all counties in Minnesota. The program’s mission aligns closely with the foundation’s broader vision: ensuring that every Minnesotan has access to safe, affordable, and sustainable housing. By focusing on single-family, owner-occupied homes, this funding opportunity aims to address both supply and quality gaps, particularly in underserved and economically marginalized communities. Through multiple financing mechanisms—grants, deferred loans, housing infrastructure bonds, and interim loans—the program seeks to foster community stability, economic inclusion, and equitable pathways to homeownership. The program’s primary beneficiaries are low- to moderate-income households, with a targeted emphasis on households of color, immigrant households, and those including people with disabilities. This focus reflects GMHF’s commitment to applying a racial and economic equity lens to homeownership initiatives, aiming to reduce historic disparities in property ownership and wealth accumulation. Targeted investments will support both the creation of new affordable housing units and the rehabilitation of existing homes, ensuring that communities not only gain new housing stock but also preserve their existing neighborhoods. Special priority will be given to applicants leveraging cross-sector collaborations—particularly in health and housing—to improve overall community well-being. Strategically, the program prioritizes projects that deliver tangible, lasting impact. Priority activities include acquisition, rehabilitation, and resale of existing properties; new construction of single-family homes; and stand-alone affordability gap assistance. Additional emphasis is placed on projects that advance Tribal housing initiatives, ensuring that Tribal Nations and communities have equitable access to homeownership opportunities. By offering flexible funding types—including forgivable loans and deferred downpayment assistance—the program allows local governments, nonprofits, Tribal entities, and developers to structure their projects to meet community-specific needs and financial realities. Expected outcomes are centered on measurable, high-impact results. Awarded projects must lead to the creation or preservation of affordable, owner-occupied homes with no more than four units, ensuring at least one unit is owner-occupied. The program anticipates that these efforts will expand the affordable housing inventory, increase homeownership rates among underrepresented populations, and stabilize neighborhoods. Success metrics will include the number of homes developed or rehabilitated, the number of households served, demographic diversity among beneficiaries, and the degree to which affordability thresholds are met and maintained. Additionally, the program seeks to generate long-term community benefits such as improved health outcomes, greater neighborhood investment, and increased intergenerational wealth. The foundation’s strategic priorities and theory of change rest on the belief that stable, affordable homeownership is a critical lever for advancing economic mobility and community resilience. By combining capital investment with equitable housing strategies, the program aims to dismantle systemic barriers to homeownership and create conditions for sustained prosperity. Through partnerships with municipalities, Tribal governments, nonprofits, and developers, Minnesota Housing and GMHF are fostering a collaborative ecosystem that ensures funding leads to meaningful, measurable, and community-driven change. This initiative is not merely about building houses—it’s about empowering people, strengthening communities, and reshaping the housing landscape in Minnesota for a more inclusive future.

Housing
City or township governments
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
$1,100,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 19, 2024

Date Added

Aug 21, 2023

This grant provides financial support and mentorship for outstanding graduate students in the U.S. who are pursuing a PhD in cancer research, helping them transition to postdoctoral training and independent research careers.

Education
State governments
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 16, 2024

Date Added

Sep 9, 2024

This funding opportunity supports researchers exploring the biological and genetic factors contributing to cancer health disparities among racial and ethnic groups, aiming to generate insights for future studies.

Education
State governments
AHRQ Mentored Research Scientist Career Development Award (K01)
$90,000
U.S. Department of Health and Human Services (Agency for Health Care Research and Quality)
Federal

Application Deadline

Nov 9, 2025

Date Added

Sep 22, 2022

This funding opportunity provides financial support and mentorship for researchers with doctoral degrees to develop their careers in health services research, focusing on improving healthcare quality and equity in the United States.

Health
State governments
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)
$500,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 27, 2024

Date Added

Jan 31, 2024

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving technology that could be utilized clinically to prevent DKA by an early warning of elevations in ketone levels.The purpose of this NOFO is to solicit applications for studies that will develop and test risk mitigation strategies that involve the clinical integration of CKM for the safe use of SGLT2i for people living with T1D so that they may benefit from the cardiac and renal protection and glucose-lowering effects of this drug class. The NOFO will support short-term, clinical trials to gain and disseminate knowledge on safety and glucose control with CKM and SGLT2i use.Possible topics include testing optimal insulin delivery in open and closed loop systems or multiple daily injections and developing clinical protocols to control or ameliorate elevated ketone levels in individuals with T1D who are receiving adjunct therapy with SGLT2i.

Food and Nutrition
State governments
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
$700,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 14, 2025

Date Added

Sep 10, 2024

This funding opportunity supports innovative research on how substance use disorders affect HIV infection and latency in the brain, encouraging collaboration among researchers in HIV, neuroscience, and addiction.

Education
State governments
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 18, 2024

Date Added

Mar 30, 2023

This grant provides funding for research on how climate change affects cancer risks, prevention, treatment, and survivorship, particularly focusing on vulnerable populations and health disparities.

Education
State governments
Provide technical assistance to the Botswana Ministry of Health to implement HIV/TB policies and services for children and adolescents living with HIV including mental health and psychosocial support and pregnant and breastfeeding women under PEPFAR
$1,500,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Feb 19, 2025

Date Added

Jul 26, 2024

This funding opportunity provides financial support to organizations that will assist Botswana's Ministry of Health in implementing national HIV policies and improving care and mental health services for children and adolescents living with HIV.

Health
State governments
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 5, 2024

Date Added

Mar 8, 2022

This funding opportunity supports collaborative projects between academic institutions and industry to develop innovative bioengineering solutions that address significant biomedical challenges and improve medical practices.

Education
State governments
Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18)
$1,350,000
HHS-AHRQ (Agency for Health Care Research and Quality)
Federal

Application Deadline

May 26, 2024

Date Added

Sep 9, 2021

The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. AHRQ's Center for Quality Improvement and Patient Safety (CQuIPS) works to ensure patient safety in multiple settings with recent efforts to increase the development of processes including measures, metrics, tools and practices to increase patient safety in the ambulatory care setting and in long-term care facilities.

Health
State governments
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 8, 2025

Date Added

Nov 20, 2024

This funding supports institutions in developing training programs for predoctoral and postdoctoral researchers in biomedical and clinical fields, with a focus on enhancing diversity and preparing trainees for successful research careers.

Education
State governments
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 7, 2024

Date Added

Nov 21, 2022

This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.

Health
State governments
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
$1,200,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 4, 2024

Date Added

Aug 30, 2024

This funding opportunity supports researchers in developing innovative strategies to eliminate HIV proteins by targeting viral RNA or proteins for degradation, with a focus on advancing new therapeutic approaches.

Health
State governments